438 related articles for article (PubMed ID: 25212638)
1. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis.
Boersen N; Carvajal MT; Morris KR; Peck GE; Pinal R
Drug Dev Ind Pharm; 2015; 41(9):1470-8. PubMed ID: 25212638
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J
Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640
[TBL] [Abstract][Full Text] [Related]
3. A dimensionless variable for the scale up and transfer of a roller compaction formulation.
Boersen N; Belair D; Peck GE; Pinal R
Drug Dev Ind Pharm; 2016 Jan; 42(1):60-69. PubMed ID: 25853293
[TBL] [Abstract][Full Text] [Related]
4. Effect of the variation in the ambient moisture on the compaction behavior of powder undergoing roller-compaction and on the characteristics of tablets produced from the post-milled granules.
Gupta A; Peck GE; Miller RW; Morris KR
J Pharm Sci; 2005 Oct; 94(10):2314-26. PubMed ID: 16136545
[TBL] [Abstract][Full Text] [Related]
5. Investigation on the effect of roller compaction on paracetamol.
Tay JYS; Han QE; Liew CV; Sia Heng PW
Pharm Dev Technol; 2020 Jan; 25(1):100-106. PubMed ID: 31583937
[TBL] [Abstract][Full Text] [Related]
6. Comparative binder efficiency modeling of dry granulation binders using roller compaction.
Gupte A; DeHart M; Stagner WC; Haware RV
Drug Dev Ind Pharm; 2017 Apr; 43(4):574-583. PubMed ID: 27977316
[TBL] [Abstract][Full Text] [Related]
7. Combining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compaction.
Dumarey M; Wikström H; Fransson M; Sparén A; Tajarobi P; Josefson M; Trygg J
Int J Pharm; 2011 Sep; 416(1):110-9. PubMed ID: 21708239
[TBL] [Abstract][Full Text] [Related]
8. A quantitative correlation of the effect of density distributions in roller-compacted ribbons on the mechanical properties of tablets using ultrasonics and X-ray tomography.
Akseli I; Iyer S; Lee HP; Cuitiño AM
AAPS PharmSciTech; 2011 Sep; 12(3):834-53. PubMed ID: 21710336
[TBL] [Abstract][Full Text] [Related]
9. Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug/matrix former particle size.
Heiman J; Tajarobi F; Gururajan B; Juppo A; Abrahmsén-Alami S
AAPS PharmSciTech; 2015 Apr; 16(2):267-77. PubMed ID: 25273028
[TBL] [Abstract][Full Text] [Related]
10. Utility of multivariate analysis in modeling the effects of raw material properties and operating parameters on granule and ribbon properties prepared in roller compaction.
Soh JL; Wang F; Boersen N; Pinal R; Peck GE; Carvajal MT; Cheney J; Valthorsson H; Pazdan J
Drug Dev Ind Pharm; 2008 Oct; 34(10):1022-35. PubMed ID: 18777445
[TBL] [Abstract][Full Text] [Related]
11. Unified compaction curve model for tensile strength of tablets made by roller compaction and direct compression.
Farber L; Hapgood KP; Michaels JN; Fu XY; Meyer R; Johnson MA; Li F
Int J Pharm; 2008 Jan; 346(1-2):17-24. PubMed ID: 17689211
[TBL] [Abstract][Full Text] [Related]
12. Particle size distribution and evolution in tablet structure during and after compaction.
Fichtner F; Rasmuson A; Alderborn G
Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
[TBL] [Abstract][Full Text] [Related]
13. Roller compaction: application of an in-gap ribbon porosity calculation for the optimization of downstream granule flow and compactability characteristics.
Gamble JF; Tobyn M; Dennis AB; Shah T
Pharm Dev Technol; 2010 Jun; 15(3):223-9. PubMed ID: 22716462
[TBL] [Abstract][Full Text] [Related]
14. Roller compaction process development and scale up using Johanson model calibrated with instrumented roll data.
Nesarikar VV; Patel C; Early W; Vatsaraj N; Sprockel O; Jerzweski R
Int J Pharm; 2012 Oct; 436(1-2):486-507. PubMed ID: 22721851
[TBL] [Abstract][Full Text] [Related]
15. Population balance modelling of ribbon milling with a new mass-based breakage function.
Olaleye B; Pozza F; Wu CY; Liu LX
Int J Pharm; 2019 Nov; 571():118765. PubMed ID: 31610282
[TBL] [Abstract][Full Text] [Related]
16. The impact of roller compaction and tablet compression on physicomechanical properties of pharmaceutical excipients.
Iyer RM; Hegde S; Dinunzio J; Singhal D; Malick W
Pharm Dev Technol; 2014 Aug; 19(5):583-92. PubMed ID: 23941645
[TBL] [Abstract][Full Text] [Related]
17. Compaction behavior of roller compacted ibuprofen.
Patel S; Kaushal AM; Bansal AK
Eur J Pharm Biopharm; 2008 Jun; 69(2):743-9. PubMed ID: 18280716
[TBL] [Abstract][Full Text] [Related]
18. Roller compaction: Effect of morphology and amorphous content of lactose powder on product quality.
Omar CS; Dhenge RM; Osborne JD; Althaus TO; Palzer S; Hounslow MJ; Salman AD
Int J Pharm; 2015 Dec; 496(1):63-74. PubMed ID: 26117279
[TBL] [Abstract][Full Text] [Related]
19. Instrumented roll technology for the design space development of roller compaction process.
Nesarikar VV; Vatsaraj N; Patel C; Early W; Pandey P; Sprockel O; Gao Z; Jerzewski R; Miller R; Levin M
Int J Pharm; 2012 Apr; 426(1-2):116-131. PubMed ID: 22286023
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of density distributions in roller-compacted ribbons using micro-indentation and X-ray micro-computed tomography.
Miguélez-Morán AM; Wu CY; Dong H; Seville JP
Eur J Pharm Biopharm; 2009 May; 72(1):173-82. PubMed ID: 19130881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
